Skip to main content
. 2017 Mar 2;4(1):e000538. doi: 10.1136/openhrt-2016-000538

Table 3.

Study endpoints after 30-day and 2-year follow-ups

Variable Immediate treatment Delayed treatment RR (95% CI) p Value
30-day follow-up n=262 (%) n=261 (%)
Combined incidence of death, reinfarction and recurrent ischaemia 9.9 14.2 0.70 (0.43 to 1.12) 0.14
  Death 1.1 1.1 1.00 (0.20 to 4.89) >0.99
 Reinfarction 1.9 0.8 2.49 (0.49 to 12.72) 0.45
 Recurrent ischaemia 7.6 12.6 0.60 (0.36 to 1.02) 0.06
2-year follow-up n=262 (%) n=259 (%)
Combined incidence of death or reinfarction 11.8 13.1 0.90 (0.57 to 1.42) 0.66
 Death 6.1 8.9 0.69 (0.37 to 1.27) 0.23
 Reinfarction 6.5 5.4 1.20 (0.60 to 2.38) 0.60

RR, relative risk.